AH: Bristol Myers Squibb, TERNS, Enliven, and Pfizer: institutional research support; Novartis and Incyte: institutional research support, personal fees. D-WK: Novartis, Bristol Myers Squibb, Pfizer, II-Yand, and Takeda: grants. JEC: Novartis, Pfizer, and Bristol Myers Squibb: grants, consulting fees. KS: Novartis: research funding, honoraria. MJM: Bristol Myers Squibb, Takeda, and Pfizer: personal fees. TPH: Novartis, Bristol Myers Squibb, and Enliven: consultancy, research funding. MB: Bristol Myers Squibb, Celgene, Pfizer, Incyte, and Novartis: consultancy and honoraria; AbbVie: consultancy. MT: Imago: consultancy; Novartis and Takeda: research funding; Constellation Pharmaceuticals and Bristol Myers Squibb: membership on board of directors or advisory committees.